# US 2012/0231060 A1 · Antimicrobial hydrogels, methods of preparation thereof, and articles therefrom

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0231060 A1
- Document ID: US20120231060A1
- Status: Published application
- Kind: A1
- Application number: 13/213,555
- Filed: 2011-08-19
- Published: 2012-09-13
- Earliest claimed: 2011-03-10
- Assignees: Agency for Science, Technology and Research; International Business Machines Corporation
- Inventors: Daniel Joseph Coady; Amanda Catherine Engler; James Lupton Hedrick; Shaoqiong Liu; Yi Yan Yang; Chuan Yang
- Web page: https://patentgrep.com/patent/US20120231060A1

## CPC

- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A01N 33/12: Quaternary ammonium compounds
- A61K 31/795: Polymers containing sulfur
- A61K 47/32: Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone}
- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS

## Abstract

A covalently crosslinked hydrogel comprises a) three or more divalent poly(alkylene oxide) chains P′ covalently linked at respective first end units to a branched first core group C′, b) three or more divalent poly(alkylene oxide) chains P″ covalently linked at respective first end units to a branched second core group C″, the chains P″ comprising respective second end units which are covalently linked to between 0% and 100% of respective second end units of chains P′ by divalent linking groups L″, and c) at least one pendant cationic block copolymer chain A′-B′. A′-B′ comprises i) a divalent block A′ comprising a poly(alkylene oxide) backbone chain having an end unit covalently linked to a second end unit of one of the chains P′ by a divalent linking group L′, and ii) a monovalent block B′ comprising a first repeat unit, the first repeat unit comprising a backbone carbonate group and a cationic side chain group.

## Claims

### Claim 1

A covalently crosslinked hydrogel comprising:
three or more divalent poly(alkylene oxide) chains P′ covalently linked at respective first end units to a branched first core group C′;
three or more divalent poly(alkylene oxide) chains P″ covalently linked at respective first end units to a branched second core group C″, the chains P″ comprising respective second end units which are covalently linked to between 0% and 100% of respective second end units of chains P′ by divalent linking groups L″; and
at least one pendant cationic block copolymer chain A′-B′ which comprises i) a divalent block A′ comprising a poly(alkylene oxide) backbone chain having an end unit covalently linked to a second end unit of one of the chains P′ by a divalent linking group L′, and ii) a monovalent block B′ comprising a first repeat unit, the first repeat unit comprising a backbone carbonate group and a cationic side chain group.

### Claim 2 (depends on 1)

The hydrogel of claim 1, wherein the first repeat unit comprises a side chain quaternary amine group.

### Claim 3 (depends on 1)

The hydrogel of claim 1, wherein the block B′ of the block copolymer A′-B′ further comprises a non-charged second repeat unit having a backbone carbonate or a backbone ester group.

### Claim 4 (depends on 1)

The hydrogel of claim 1, wherein the first branched core group C′ and the second branched core group C″ is a pentaerythritolyl group (C(CH2O—*)4.

### Claim 5 (depends on 1)

The hydrogel of claim 1, wherein L′ and L″ comprise a backbone beta-sulfido carbonyl group having the structure:

### Claim 6 (depends on 1)

The hydrogel of claim 1, wherein the poly(alkylene oxide) backbone of block A′ of the block copolymer A′-B′ comprises a repeat unit selected from ethylene oxide *—(CH2CH2O)—*, propylene oxide *—(CH2CH(CH3)O)—*, and combinations thereof.

### Claim 7 (depends on 1)

The hydrogel of claim 1, wherein poly(alkylene oxide) chains P′ and chains P″ independently comprise a repeat unit selected from ethylene oxide *—(CH2CH2O)—*, propylene oxide *—(CH2CH(CH3)O)—*, and combinations thereof.

### Claim 8 (depends on 1)

The hydrogel of claim 1, wherein block B′ of the block copolymer A′-B′ comprises an end unit capable of initiating a ring opening polymerization of a cyclic carbonyl compound.

### Claim 9 (depends on 1)

The hydrogel of claim 1, wherein the hydrogel is an effective antimicrobial agent against at least a Gram positive microbe.

### Claim 10 (depends on 1)

The hydrogel of claim 1, further comprising at least one pendant non-charged block copolymer chain D′-E′ comprising i) a divalent block D′ comprising a poly(alkylene oxide) backbone chain having an end unit covalently linked by a divalent linking group L″′ to one of the second end units of chains P′, wherein L″′ comprises a backbone sulfide group, and ii) a monovalent hydrophobic block E′, wherein block E′ comprises a repeat unit comprising a backbone carbonate group and a side chain urea group.

### Claim 11 (depends on 1)

A method of forming the hydrogel of claim 1, comprising:
combining i) a first crosslinking agent C′[—P′—F′]t′, ii) a cationic nucleophilic block copolymer Na-A′-B′, iii) a base; and iv) a second crosslinking agent C″[—P″—Nb]u′, thereby forming a hydrogel precursor mixture; and
allowing and/or inducing the hydrogel precursor mixture to crosslink, thereby forming the hydrogel;
wherein
i) C′[—P′—F′]t′ comprises t′≧3 independent divalent poly(alkylene oxide) chains P′ comprising respective first end units covalently linked to a branched first core group C′ and respective electrophilic second end units F′,
ii) Na-A′-B′ is formed by organocatalyzed ring opening polymerization, and Na-A′-B′ comprises a) a divalent block A′ comprising a poly(alkylene oxide) backbone linked to a nucleophilic end unit Na capable of reacting with F′ to form a divalent linking group L′, and b) a monovalent cationic block B′ comprising a first repeat unit, the first repeat unit comprising a backbone carbonate group and a cationic side chain group, and
iii) C″[—P″—Nb]u′ comprises u′≧3 independent divalent poly(alkylene oxide) chains P″ comprising respective first end units covalently linked to a second branched core group C″ and respective nucleophilic second end units Nb, wherein each of the second end units is capable of reacting with F′ to form a divalent linking group L″.

### Claim 12 (depends on 1)

A method, comprising contacting a microbe with the covalently crosslinked hydrogel of claim 1, thereby killing the microbe.

### Claim 13 (depends on 1)

An article comprising the covalently crosslinked hydrogel of claim 1 disposed on a surface of a medical device.

### Claim 14 (depends on 13)

The article of claim 13, wherein the medical device is selected from the group consisting of swabs, catheters, sutures, stents, bedpans, gloves, facial masks, absorbent pads, absorbent garments, internal absorbent devices, insertable mechanical devices, and wound dressings.

### Claim 15

A covalently crosslinked hydrogel of formula (1):
wherein
starred bonds indicate attachment points,
A′-B′ is a pendant cationic block copolymer comprising i) a divalent block A′ comprising a poly(alkylene oxide) backbone and ii) a monovalent block B′ comprising a first repeat unit, the first repeat unit comprising a backbone carbonate group and a cationic side chain group,
D′-E′ is an optional pendant non-charged amphiphilic block copolymer comprising i) a block D′ comprising a poly(alkylene oxide) backbone and a hydrophobic block E′,
each C′ is an independent branched first core group comprising at least one carbon and having a valency of t′,
t′ is an integer greater than or equal to 3,
each C″ is an independent branched second core group comprising at least one carbon and having a valency of u′,
u′ is an integer greater than or equal to 3,
each P′ is an independent divalent poly(alkylene oxide) chain,
each P″ is an independent divalent poly(alkylene oxide) chain,
each C′ is linked to t′ number of chains P′,
each C″ is linked to u′ number of chains P″,
each L′ is an independent divalent linking group that covalently links a chain P′ to a block A′,
each L″ is an independent divalent linking group that covalently links a chain P′ to a chain P″,
each L″′ is an optional independent divalent linking group that covalently links a chain P′ to a block D′,
q′ is a number greater than 0 representing moles of C′ in the hydrogel,
j′ is a number greater than 0 representing moles of C″ in the hydrogel,
k′ is a number greater than 0 representing moles of block copolymer A′-B′ in the hydrogel,
i′ is a number greater than or equal to 0 representing moles of optional block copolymer D′-E′ in the hydrogel, and
between 0% and 100% of the chains P′ are independently covalently linked to chains P″.

### Claim 16 (depends on 15)

The hydrogel of claim 15, wherein the first repeat unit comprises a side chain quaternary amine group.

### Claim 17 (depends on 15)

The hydrogel of claim 15, wherein block E′ comprises a side chain urea group.

### Claim 18 (depends on 15)

The hydrogel of claim 15, wherein the hydrogel is an effective antimicrobial agent at least a Gram positive microbe.

### Claim 19 (depends on 15)

A composition comprising i) the hydrogel of claim 15 and ii) a drug and/or a gene.

### Claim 20

A method, comprising:
forming a mixture comprising
i) a first crosslinking agent C′[—P′—F′]t′ comprising t′≧3 independent divalent poly(alkylene oxide) chains P′ comprising respective first end units covalently linked to a branched first core group C′ and respective electrophilic second end units F′,
ii) a cationic nucleophilic block copolymer Na-A′-B′ formed by organocatalyzed ring opening polymerization, Na-A′-B′ comprising a) a divalent block A′ comprising a poly(alkylene oxide) backbone linked to a nucleophilic end unit Na capable of reacting with F′ to form a divalent linking group L′, and b) a monovalent cationic block B′ comprising a first repeat unit, the first repeat unit comprising a backbone carbonate group and a cationic side chain group,
iii) a base, and optionally
iv) a nucleophilic non-charged amphiphilic block copolymer Nc-D′-E′ formed by organocatalyzed ring opening polymerization, Nc-D′-E′ comprising a) a divalent block D′ comprising a poly(alkylene oxide) backbone chain having a nucleophilic end unit Nc capable of reacting with F′ to form a divalent linking group L″′, and b) a monovalent hydrophobic block E;
agitating the mixture, thereby forming an adduct, wherein the adduct comprises unreacted electrophilic groups F′;
forming a hydrogel precursor mixture comprising i) the adduct and a second crosslinking agent C″[—P″—Nb]u′ comprising u′≧3 independent divalent poly(alkylene oxide) chains P″ comprising respective first end units covalently linked to a second branched core group C″ and respective nucleophilic second end units Nb capable of reacting with F′ to form a divalent linking group L″;
disposing the hydrogel precursor mixture on a surface of a substrate, thereby forming a hydrogel precursor layer disposed on the surface; and
allowing and/or inducing the hydrogel precursor layer to crosslink, thereby forming an antimicrobial layer comprising a covalently crosslinked cationic hydrogel disposed on the surface of the substrate.

### Claim 21 (depends on 21)

The method of claim 21, wherein the first repeat unit of block B′ comprises a side chain quaternary amine group.

### Claim 22 (depends on 21)

The method of claim 21, wherein the hydrogel precursor mixture further comprises a drug and/or a gene, and the antimicrobial layer comprises the hydrogel and the gene and/or the drug occluded therein.

### Claim 23

A covalently crosslinked hydrogel of formula (1a):
wherein
starred bonds indicate attachment points,
A′-B′ is a pendant cationic block copolymer comprising i) a divalent block A′ comprising a poly(alkylene oxide) backbone and ii) a monovalent cationic block B′ comprising a first repeat unit, the first repeat unit comprising a backbone carbonate group and a cationic side chain group,
D′-E′ is a pendant non-charged amphiphilic block copolymer comprising i) a block D′ comprising a poly(alkylene oxide) backbone and a hydrophobic block E′,
each C′ is an independent branched first core group comprising at least one carbon and having a valency of t′,
t′ is an integer greater than or equal to 3,
each C″ is an independent branched second core group comprising at least one carbon and having a valency of u′,
u′ is an integer greater than or equal to 3,
each P′ is an independent divalent poly(alkylene oxide) chain,
each P″ is an independent divalent poly(alkylene oxide) chain,
each L′ is an independent divalent linking group that covalently links a chain P′ to a block A′,
each L″ is an independent divalent linking group that covalently links a chain P′ to a chain P″,
each L″′ is an independent divalent linking group that covalently links a chain P′ to a block D′,
each S′ is an independent non-polymeric core group comprising at least one carbon and having a valency of v′, wherein v′ is a positive integer greater than or equal to 2,
each S″ is an independent non-polymeric core group comprising at least one carbon and having a valency of w′, wherein w′ is a positive integer greater than or equal to 2,
each La is an independent divalent linking group that covalently links a S″ group to a chain P′,
each Ma is an independent divalent linking group that covalently links a S″ group to a S′ group,
each M′ is an independent divalent linking group that covalently links a S′ group to a block A′ of block copolymer A′-B′,
M″ is an independent divalent linking group that covalently links a S′ group to a chain P″,
M″′ is an independent divalent linking group that covalently links a S′ group to a block D′ of block copolymer D′-E′,
a′ is a number greater than 0 representing moles of A′-B′ linked to chains P′ in the hydrogel,
b′ is a number greater than or equal to 0 representing moles of A′-B′ linked to S′ in the hydrogel,
d′ is a number greater than or equal to 0 representing moles of D′-E′ linked to chains P′ in the hydrogel,
e′ is a number greater than or equal to 0 representing moles of D′-E′ linked to S′ in the hydrogel,
q′ is a number greater than 0 representing moles of C′ in the hydrogel,
x′ is a number greater than 0 representing moles of C″ in the hydrogel,
y′ is a number greater than or equal to 0 representing moles of S″ in the hydrogel,
r′ is a number greater than or equal to 0 representing moles of S′ in the hydrogel,
each C′ is linked to t′ number of chains P′,
each C″ is linked to u′ number of chains P″,
each S′ group is linked to v′ number of linking groups independently selected from the group consisting of M′, M″, M″′, and Ma,
each S″ group is linked to w′ number of linking groups independently selected from the group consisting of La and Ma, and
between 0% and 100% of the chains P′ are independently covalently linked to chains P″ in the hydrogel.

### Claim 24 (depends on 23)

The hydrogel of claim 23, wherein the first repeat unit comprises a side chain quaternary amine group.

### Claim 25 (depends on 23)

The hydrogel of claim 23, wherein block E′ comprises a random copolycarbonate and/or copolyestercarbonate backbone, and a repeat unit having a side chain urea group.

### Claim 26 (depends on 23)

A composition comprising i) the hydrogel of claim 23 and ii) a gene and/or a drug.

### Claim 27 (depends on 26)

An article, comprising the composition of claim 26 disposed on a surface of a medical device.

### Claim 28 (depends on 27)

The article of claim 27, wherein the medical device is selected from the group consisting of swabs, catheters, sutures, stents, bedpans, gloves, facial masks, absorbent pads, absorbent garments, internal absorbent devices, insertable mechanical devices, and wound dressings.

### Claim 29

A method, comprising:
combining i) a first crosslinking agent C′[—P′—F′]t′, optionally ii) an electrophilic non-polymeric crosslinking agent, S′[—F″]v′, iii) a cationic nucleophilic block copolymer Na-A′-B′, iv) a base; optionally v) a nucleophilic non-charged amphiphilic block copolymer Nc-D′-E′, vi) a second crosslinking agent C″[—P″—Nb]u′, and optionally vii) a nucleophilic non-polymeric crosslinking agent S″[—Nd]w′, thereby forming a hydrogel precursor mixture; and
allowing and/or inducing the hydrogel precursor mixture to crosslink, thereby forming a covalently crosslinked hydrogel;
wherein
i) C′[—P′—F′]t′ comprises t′≧3 independent divalent poly(alkylene oxide) chains P′ comprising respective first end units covalently linked to a branched first core group C′ and respective electrophilic second end units F′,
ii) S′[—F″]v′ comprises v′≧2 independent electrophilic groups F″ and a non-polymeric core group S′ comprising at least one carbon,
iii) Na-A′-B′ is formed by organocatalyzed ring opening polymerization, and Na-A′-B′ comprises a) a divalent block A′ comprising a poly(alkylene oxide) backbone linked to a nucleophilic end unit Na capable of reacting with F′ to form a divalent linking group L′ and/or reacting with F″ to form a divalent linking group M′, and b) a monovalent cationic block B′ comprising a first repeat unit, the first repeat unit comprising a backbone carbonate group and a cationic side chain group,
iv) Nc-D′-E′ is formed by organocatalyzed ring opening polymerization, and Nc-D′-E′ comprises a) a divalent block D′ comprising a poly(alkylene oxide) backbone chain having an end unit Nc capable of reacting with F′ to form a divalent linking group L″′ and/or reacting with F″ to form divalent linking group M″′, and b) a monovalent block E;
v) C″[—P″—Nb]u′ comprises u′≧3 independent divalent poly(alkylene oxide) chains P″ comprising respective first end units covalently linked to a second branched core group C″ and respective nucleophilic second end units Nb, wherein each of the second end units is capable of reacting with F′ to form a divalent linking group L″ and/or reacting with F″ to form a divalent linking group M″, and
vi) S″[—Nd]w′ comprises w′≧2 nucleophilic groups Nd and a non-polymeric core group S″ comprising at least one carbon, wherein Nd is capable of reacting with F′ to form a divalent linking group La and/or reacting with F″ to form a divalent linking group Ma.

### Claim 30 (depends on 29)

The method of claim 29, wherein the first repeat unit of block B′ comprises a side chain quaternary amine group.

### Claim 31 (depends on 29)

The method of claim 29, wherein F′ and/or F″ react by a Michael addition reaction, thereby forming the hydrogel.

### Claim 32 (depends on 29)

The method of claim 29, wherein block E′ of Nc-D′-E′ comprises a side chain urea group.

### Claim 33 (depends on 29)

The method of claim 29, wherein the hydrogel precursor mixture further comprises a gene and/or a drug, and the hydrogel is a loaded hydrogel comprising the gene and/or the drug occluded therein.

### Claim 34 (depends on 29)

The method of claim 29, further comprising disposing the hydrogel precursor mixture on a surface of a substrate before substantial crosslinking occurs, thereby forming a hydrogel precursor layer; and allowing and/or inducing the hydrogel precursor layer to crosslink, thereby forming an antimicrobial layer comprising the hydrogel disposed on the surface of the substrate.

### Claim 35 (depends on 34)

The method of claim 34, wherein the substrate is a medical device selected from the group consisting of swabs, catheters, sutures, stents, bedpans, gloves, facial masks, absorbent pads, absorbent garments, internal absorbent devices, insertable mechanical devices, and wound dressings.
